Timothy Donahue
Overview
Explore the profile of Timothy Donahue including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
654
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Andersen D, Wiseman D, Foster D, Appel E, Cardenas J, Zindel J, et al.
J Am Coll Surg
. 2025 Feb;
PMID: 40013692
No abstract available.
2.
Wang J, Ganjouei A, Romero-Hernandez F, Foroutani L, Bahceci D, Deranteriassian A, et al.
Ann Surg
. 2024 Aug;
PMID: 39176476
Objective: To evaluate the feasibility of developing a computer vision algorithm that uses preoperative computed tomography (CT) scans to predict superior mesenteric artery (SMA) margin status in patients undergoing Whipple...
3.
Bahdi F, Labora A, Shah S, Farooq M, Wangrattanapranee P, Donahue T, et al.
Gastro Hep Adv
. 2024 Aug;
3(3):370-384.
PMID: 39131137
The continuous evolution of endoscopic tools over the years has paved the way for minimally invasive alternatives to surgical procedures for multiple gastrointestinal conditions. While few endoscopic techniques have supplanted...
4.
Gaffney C, Vertosick E, Laudone V, Goh A, Carlsson S, Pietzak E, et al.
J Urol
. 2024 Aug;
212(3):401-408.
PMID: 39115122
Purpose: Incisional hernias are a frequent complication following robotic radical prostatectomy. Observational data in men undergoing robotic prostatectomy suggest that transverse closure resulted in lower hernia rates than vertical closure....
5.
Chervu N, Kim S, Sakowitz S, Le N, Mallick S, Lee H, et al.
Surg Open Sci
. 2024 Jul;
20:101-105.
PMID: 39021616
Background: Multiagent neoadjuvant chemotherapy (NAT) has been linked with improved survival for locally advanced (LA) or borderline resectable (BR) pancreatic ductal adenocarcinoma (PDAC). However, the existence of disparities in its...
6.
Moore A, Lobaugh S, Zhang Z, Rosenberg J, Iyer G, Teo M, et al.
Bladder Cancer
. 2024 Jul;
9(2):141-150.
PMID: 38993294
Background: Various radiotherapeutic regimens are used in the treatment of bladder cancer. Objective: We aimed to evaluate early toxicity and outcomes associated with hypofractionated radiation therapy (Hypo-RT), 55Gy in 20...
7.
Dillon D, Park J, Mederos M, Seo Y, King J, Hines J, et al.
J Surg Oncol
. 2024 May;
130(1):72-82.
PMID: 38726668
Background And Objectives: Neoadjuvant chemotherapy (NAC) is becoming favored for all pancreatic adenocarcinoma (PDAC). Patients with seemingly resectable disease infrequently still display vascular involvement intraoperatively. Outcomes following NAC versus upfront...
8.
Shimizu T, Maeda S, Link J, Deranteriassian A, Premji A, Verma A, et al.
Surgery
. 2024 Feb;
175(5):1377-1385.
PMID: 38365548
Background: Neoadjuvant therapy is being increasingly used for patients with pancreatic cancer. The role of adjuvant therapy in these patients is unclear. The purpose of this study was to identify...
9.
Kim S, Chervu N, Premji A, Mallick S, Verma A, Ali K, et al.
Ann Surg Oncol
. 2023 Dec;
31(2):1362-1363.
PMID: 38063981
No abstract available.
10.
Kim S, Chervu N, Premji A, Mallick S, Verma A, Ali K, et al.
Ann Surg Oncol
. 2023 Nov;
31(2):1328-1335.
PMID: 37957512
Background: Palliative care consultation (PCC) has been shown to improve quality of life and reduce costs for various chronic life-threatening diseases. Despite PCC incorporation into modern pancreatic cancer care guidelines,...